Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Fundación Renal Iñigo Alvarez de Toledo
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Renal Iñigo Alvarez de Toledo (8)
2015
-
A labor and cost effective next generation sequencing of PKHD1 in autosomal recessive polycystic kidney disease patients
Gene, Vol. 561, Núm. 1, pp. 165-169
-
ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach
Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519
2014
-
Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients
Gene, Vol. 538, Núm. 1, pp. 195-198
2012
-
Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus
Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527
2011
-
Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))
Clinical Chemistry and Laboratory Medicine
-
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients
Clinical Transplantation, Vol. 25, Núm. 3
-
Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Clinical Chemistry and Laboratory Medicine, Vol. 49, Núm. 5, pp. 825-833
-
Pharmacogenetics of tacrolimus: Ready for clinical translation
Kidney International Supplements, Vol. 1, Núm. 2, pp. 58-62